Hematopoiesis Regulation
Hematopoiesis Regulation - Related Videos
01:21
Hematopoiesis
0 Views •
2025
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
01:20
Overview of Hematopoiesis
0 Views •
2024
Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs). Developmental Phases of Hematopoiesis Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
11:50
Ex vivo Mimicry of Normal and Abnormal Human Hematopoiesis
0 Views •
Cited by 9 •
2012
A 3D culture system for hematopoiesis is described using human cord blood and leukemic bone marrow cells. The method is based on the use of a porous synthetic polyurethane scaffold coated with extracellular matrix proteins. This scaffold is adaptable to accommodate a wide range of cells.
01:46
Epigenetic Regulation
0 Views •
2019
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer. In most mammals, females have two X chromosomes (XX) while males have an X and a Y chromosome (XY). The X chromosome contains significantly more genes than the Y chromosome. Therefore, to prevent an excess of X chromosome-linked gene expression in females, one of the two X chromosomes is randomly silenced during early development.
02:14
GTPases and their Regulation
0 Views •
2020
Guanine nucleotide-binding proteins (G-proteins), also known as GTPases, are a superfamily of proteins that regulate many cellular processes, such as cell signaling, vesicular transport, and the regulation of cell shape and motility. Mutation or dysfunction of these proteins can lead to disease. There are around 40,000 known G-proteins that can broadly be classified into two groups ‒ small G-proteins consisting of a single domain and large multi-domain G-proteins. Large G-proteins, also known...
FAQs
The bone marrow niche provides local signals that influence whether hematopoietic stem cells remain in a self-renewing state or enter differentiation pathways. Cytokines, growth factors, and interactions with neighboring cells help connect the stem-cell compartment to broader physiological needs. This local control allows blood production to adjust within the marrow environment rather than operating independently of surrounding tissues.
Self-renewal preserves the stem-cell pool, whereas differentiation produces committed descendants for erythrocyte, leukocyte, and platelet formation. Regulation must coordinate these outcomes because excessive commitment could reduce the reservoir, while insufficient differentiation could limit mature blood-cell supply. This balance provides a mechanistic basis for lifelong blood production and helps explain how disrupted control can contribute to bone marrow failure.
Hematopoiesis regulation links production to changing physiological conditions through feedback from oxygen availability, inflammation, and circulating blood-cell levels. These inputs can alter the intensity or direction of production according to demand, helping maintain adequate supplies during ordinary conditions and respond when needs change. Considering the signals together is important because no single input fully represents systemic demand.
Transcriptional programs convert external and internal signals into lineage-specific decisions within hematopoietic stem and progenitor cells. By guiding commitment toward particular blood-cell lineages, these programs help determine which cell types are produced and in what balance. Their interaction with cytokines, growth factors, niche contacts, and feedback signals creates a coordinated regulatory network rather than a single controlling switch.
Abnormal regulation can help explain distinct blood disorders by linking changes in regulatory control to changes in blood-cell production. Insufficient or poorly balanced production may be associated with anemia or bone marrow failure, whereas dysregulated lineage programs are relevant to leukemia. This perspective encourages biology research to interpret disease as a problem of regulatory networks, not only of mature cell counts.
Knowledge of these networks supports research and medical strategies involving stem-cell transplantation, regenerative medicine, and targeted therapies. The value lies in identifying how niche signals, feedback conditions, and lineage programs shape blood-cell output. That understanding provides biological context for efforts to restore production, improve control of abnormal hematopoiesis, or direct treatment toward specific regulatory pathways.